InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by ENGLEMAN EDGAR. Officer active across 2 companies, notably Bolt Biotherapeutics, Inc.. In total, 7 disclosures have been recorded. Split: 0 buy · 3 sells. Total volume traded: €27k. Activity tracked since 16 November 2023. The latest transaction was filed on 29 November 2023 (Cession). Regulator: SEC (Form 4). All data is openly available.
7 of 7 declarations